Study to Assess dHER2+AS15 Cancer Vaccine Given in Combination With Lapatinib to Patients With Metastatic Breast Cancer
This study has been completed.
Sponsor:
Michael Morse, MD
Collaborator:
GlaxoSmithKline
Information provided by (Responsible Party):
Michael Morse, MD, Duke University Medical Center
ClinicalTrials.gov Identifier:
NCT00952692
First received: August 4, 2009
Last updated: November 15, 2012
Last verified: November 2012
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study has been completed. |
|---|---|
| Study Completion Date: | April 2012 |
| Primary Completion Date: | July 2011 (Final data collection date for primary outcome measure) |
| Certification or Request for Extension to Delay Results Received: | November 15, 2012 |